Table 1.
Patients’ demographic and clinical characteristics stratified by surgical procedure
| Variable | Total | Nailing (n = 17) | Plating (n = 28) | p-Value |
|---|---|---|---|---|
| Age, years | 61.7 ± 9.7 | 66.6 ± 9.8 | 58.7 ± 8.5 | 0.006 |
| Sex | 0.848 | |||
| Male | 22 (48.9) | 8 (47.1) | 14 (50.0) | |
| Female | 23 (51.1) | 9 (52.9) | 14 (50.0) | |
| Site | 0.977 | |||
| Left | 16 (35.6) | 6 (35.3) | 10 (35.7) | |
| Right | 29 (64.4) | 11 (64.7) | 18 (64.3) | |
| Lesion site in the humerus | 0.908a | |||
| Head and neck | 17 (37.8) | 6 (35.3) | 11 (39.3) | |
| Neck | 24 (53.3) | 9 (52.9) | 15 (53.6) | |
| Head, neck to shaft | 4 (8.9) | 2 (11.8) | 2 (7.1) | |
| Bone metastases site | 0.848 | |||
| Solitary | 23 (51.1) | 9 (52.9) | 14 (50.0) | |
| Multiple | 22 (48.9) | 8 (47.1) | 14 (50.0) | |
| Diagnosis | 0.789 | |||
| Pathological fracture | 17 (37.8) | 6 (35.3) | 11 (39.3) | |
| Impending fracture | 28 (62.2) | 11 (64.7) | 17 (60.7) | |
| Primary tumor | 0.368a | |||
| Lung | 15 (33.3) | 6 (35.3) | 9 (32.1) | |
| Breast | 10 (22.2) | 3 (17.6) | 7 (25.0) | |
| HCC | 9 (20.0) | 4 (23.5) | 5 (17.9) | |
| Lymphoma | 1 (2.2) | 0 (0.0) | 1 (3.6) | |
| Melanoma | 1 (2.2) | 1 (5.9) | 0 (0.0) | |
| Cholangiocarcinoma | 1 (2.2) | 1 (5.9) | 0 (0.0) | |
| Bladder | 1 (2.2) | 1 (5.9) | 0 (0.0) | |
| Prostate | 7 (15.6) | 1 (5.9) | 6 (21.4) |
P-Value < 0.05 is shown in bold
HCC, hepatocellular carcinoma
a. Fisher’s exact test